ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 83 filers reported holding ANTARES PHARMA INC in Q2 2013. The put-call ratio across all filers is 6.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $592,000 | +15.2% | 144,400 | +0.3% | 0.00% | – |
Q4 2021 | $514,000 | -52.1% | 143,900 | -51.2% | 0.00% | – |
Q3 2021 | $1,073,000 | +71.1% | 294,879 | +104.9% | 0.00% | – |
Q2 2021 | $627,000 | +15.3% | 143,900 | +8.8% | 0.00% | – |
Q1 2021 | $544,000 | -9.3% | 132,300 | -12.0% | 0.00% | – |
Q4 2020 | $600,000 | +56.7% | 150,400 | +6.0% | 0.00% | – |
Q3 2020 | $383,000 | -8.4% | 141,900 | -6.6% | 0.00% | – |
Q2 2020 | $418,000 | +15.8% | 151,900 | -0.7% | 0.00% | – |
Q1 2020 | $361,000 | -49.8% | 153,000 | 0.0% | 0.00% | – |
Q4 2019 | $719,000 | +40.4% | 153,000 | 0.0% | 0.00% | – |
Q3 2019 | $512,000 | +1.8% | 153,000 | 0.0% | 0.00% | – |
Q2 2019 | $503,000 | +17.2% | 153,000 | +8.1% | 0.00% | – |
Q1 2019 | $429,000 | +15.6% | 141,600 | +3.9% | 0.00% | – |
Q4 2018 | $371,000 | +12.8% | 136,300 | +39.1% | 0.00% | – |
Q3 2018 | $329,000 | +49.5% | 98,000 | +14.9% | 0.00% | – |
Q2 2018 | $220,000 | +60.6% | 85,300 | +36.9% | 0.00% | – |
Q1 2018 | $137,000 | +38.4% | 62,300 | +25.6% | 0.00% | – |
Q4 2017 | $99,000 | -17.5% | 49,600 | +34.4% | 0.00% | – |
Q3 2017 | $120,000 | +0.8% | 36,900 | 0.0% | 0.00% | – |
Q2 2017 | $119,000 | -27.0% | 36,900 | -80.2% | 0.00% | – |
Q1 2016 | $163,000 | -31.5% | 186,800 | -5.1% | 0.00% | – |
Q4 2015 | $238,000 | -29.0% | 196,800 | -0.3% | 0.00% | – |
Q3 2015 | $335,000 | -18.3% | 197,300 | 0.0% | 0.00% | – |
Q2 2015 | $410,000 | -23.4% | 197,300 | 0.0% | 0.00% | – |
Q1 2015 | $535,000 | +5.5% | 197,300 | 0.0% | 0.00% | – |
Q4 2014 | $507,000 | +33.4% | 197,300 | -5.1% | 0.00% | – |
Q3 2014 | $380,000 | -35.6% | 207,900 | -6.0% | 0.00% | – |
Q2 2014 | $590,000 | -23.9% | 221,100 | -0.1% | 0.00% | -100.0% |
Q1 2014 | $775,000 | -25.8% | 221,389 | -5.1% | 0.00% | 0.0% |
Q4 2013 | $1,045,000 | +4.1% | 233,223 | -5.7% | 0.00% | 0.0% |
Q3 2013 | $1,004,000 | +3.8% | 247,223 | +6.3% | 0.00% | 0.0% |
Q2 2013 | $967,000 | – | 232,498 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 1,671,956 | $5,384,000 | 3.43% |
ARMISTICE CAPITAL, LLC | 5,700,000 | $18,354,000 | 2.34% |
Rubric Capital Management LP | 3,188,600 | $10,267,000 | 2.12% |
Broadfin Capital, LLC | 4,803,528 | $15,467,000 | 1.88% |
THOMPSON DAVIS & CO., INC. | 192,734 | $621,000 | 1.00% |
Asymmetry Capital Management, L.P. | 199,655 | $643,000 | 0.76% |
Perceptive Advisors | 4,267,253 | $13,741,000 | 0.69% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 946,987 | $3,049,000 | 0.21% |
Brown Advisory Securities, LLC | 275,000 | $886,000 | 0.20% |
EAM Investors, LLC | 251,619 | $810,000 | 0.13% |